[ Price : $8.95]
Novartis reports that a Phase 3 trial of its oral complement inhibitor Fabhalta (iptacopan) showed the therapy slowed kidney funct...[ Price : $8.95]
Two academic researchers urge FDA to require a Drug Facts box in direct-to-consumer ads so consumers can understand a drugs benefi...[ Price : $8.95]
Johnson & Johnson says an independent data monitoring committee recommended unblinding the MajesTEC-3 study of Tecvayli and Darzal...[ Price : $8.95]
Hyman, Phelps & McNamara principal medical device regulation expert Adrienne Lenz says FDA is preparing for a future where artific...[ Price : $8.95]
FDA urges the Supreme Court to reject Vanda Pharmaceuticals petition challenging the agencys decision to deny fast-track status fo...[ Price : $8.95]
FDA releases the form FDA-483 with three observations from its inspection at the Lupin drug manufacturing facility in Pithampur, M...[ Price : $8.95]
Minovia Therapeutics wins an FDA orphan drug designation for its lead investigational therapy, MNV-201, for myelodysplastic syndro...[ Price : $8.95]
FDA accepts for review a Chiesi NDA for a single-inhaler triple therapy designed for the maintenance treatment of asthma in adults...